#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


Representació teatral “Abans que arribi l’alemany” i col·loqui sobre la malaltia d’Alzheimer. En el marc de la Setmana del Cervell.

Dissabte, 18 de març, a les 18:00 h, al Centre Catòlic de L’Hospitalet. Representació de l’obra de…

Read More

#IDIBELLfellows: Jasin Taelman / Victor Daniel Gumucio

Modelling intestinal injury and recovery from irradiation using human intestinal organoids Jasin Taelman Cell Plasticity and Regeneration…

Read More

#IDIBELLseminars: Functional Genomics for Cancer Drug Discovery and Modelling Therapy Response

We have an increasingly detailed understanding of the molecular alterations that occur across the diversity of human…

Read More

Oportunitats de finançament internacional en salut: els partenariats en Horizon Europe i H2020 (accions ERANET)

14 de març 2022. Sala Actes Pavelló Govern, UB (Planta 1)  15h Benvinguda Fernando Fernández Aranda. Director…

Read More

Taula rodona “Dones i ciència. Trajectòries de vida” 

6 de març – 13 h – Aula de Graus del Campus de Bellvitge de la Universitat…

Read More

How to publish a paper with Cell Press

How to publish a paper with Cell Press Salvatore Fabbiano – Senior Scientific Editor, Cell Press Hosted…

Read More

#IDIBELLseminars: The unknowns behinds the rise of multicellularity on Earth

The rise of large life on Earth in the form of animals was a fairly late and…

Read More

#IDIBELLseminars: Structural insights into TGF beta signaling

SMAD proteins are highly conserved transcription factors that act as downstream effectors of Transforming Growth Factor Beta…

Read More

#IDIBELLfellows: Lejuan Shi / David Piñol

Role of Macrosatellite NBL2 and its Associated LncRNA in Cancer Lejuan Shi Immunity, inflammation, and cancer group…

Read More

#IDIBELLseminars: Aging: vascular dysfunction at the driver seat

The increase in lifespan witnessed during the last century is unfortunately associated with more years of poor…

Read More
Scroll to Top